Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wallach

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Investigation|January 1, 1972
Angiotensin II vascular receptors: their avidity in relationship to sodium balance, the autonomic nervous system, and hypertensionH R Brunner, P Chang, R Wallach, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 26, 2007
Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individualsS Jones, D de Gijsel, F R Wallach, et al.
Cancer Treatment Reviews|March 1, 1991
Hexamethylmelamine for the treatment of ovarian cancer--the Mount Sinai experienceH W Bruckner, C Cohen, J Mandeli, et al.
The American Journal of Cardiology|October 1, 1980
Pathogenesis of paroxysmal hypertension developing during and after coronary bypass surgery: a study of hemodynamic and humoral factorsR Wallach, R B Karp, J G Reves, et al.
Gynecologic Oncology|August 1, 1981
High-dose platinum for the treatment of refractory ovarian cancerH W Bruckner, R Wallach, C J Cohen, et al.
Gynecologic Oncology|October 1, 1981
Treatment of chemotherapy-resistant advanced ovarian cancer with a combination of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-diamminedichloroplatinum (CHAP)H W Bruckner, C J Cohen, G Deppe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Activity and pharmacodynamics of 21-Day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy. New York Gynecologic Oncology GroupH Hochster, S Wadler, C Runowicz, et al.
Gynecologic Oncology|March 4, 1999
A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancerH Hochster, J L Speyer, J P Mandeli, et al.
Cancer Treatment Reports|July 1, 1978
Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapyH W Bruckner, L H Ratner, C J Cohen, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2015
Synthesis and initial evaluation of quinoline-based inhibitors of the SH2-containing inositol 5'-phosphatase (SHIP)Christopher M Russo, Arijit A Adhikari, Daniel R Wallach, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Investigation|January 1, 1972
Angiotensin II vascular receptors: their avidity in relationship to sodium balance, the autonomic nervous system, and hypertensionH R Brunner, P Chang, R Wallach, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 26, 2007
Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individualsS Jones, D de Gijsel, F R Wallach, et al.
Cancer Treatment Reviews|March 1, 1991
Hexamethylmelamine for the treatment of ovarian cancer--the Mount Sinai experienceH W Bruckner, C Cohen, J Mandeli, et al.
The American Journal of Cardiology|October 1, 1980
Pathogenesis of paroxysmal hypertension developing during and after coronary bypass surgery: a study of hemodynamic and humoral factorsR Wallach, R B Karp, J G Reves, et al.
Gynecologic Oncology|August 1, 1981
High-dose platinum for the treatment of refractory ovarian cancerH W Bruckner, R Wallach, C J Cohen, et al.
Gynecologic Oncology|October 1, 1981
Treatment of chemotherapy-resistant advanced ovarian cancer with a combination of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-diamminedichloroplatinum (CHAP)H W Bruckner, C J Cohen, G Deppe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Activity and pharmacodynamics of 21-Day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy. New York Gynecologic Oncology GroupH Hochster, S Wadler, C Runowicz, et al.
Gynecologic Oncology|March 4, 1999
A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancerH Hochster, J L Speyer, J P Mandeli, et al.
Cancer Treatment Reports|July 1, 1978
Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapyH W Bruckner, L H Ratner, C J Cohen, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2015
Synthesis and initial evaluation of quinoline-based inhibitors of the SH2-containing inositol 5'-phosphatase (SHIP)Christopher M Russo, Arijit A Adhikari, Daniel R Wallach, et al.
Pageof 5